Q&A: FDA Panel Member Tells Healthline Why He Resigned Over Alzheimer’s Drug Approval
An interview between Healthline and former FDA panel member. Dr. Aaron S. Kesselheim, MPH, began advising the Food and Drug Administration (FDA) in 2015, and then joined one of its advisory panels as a permanent…